OCM
VRTX icon

Orion Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Orion Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3K Hold
32
– – ﹤0.01% 344
2025
Q4 		$14.5K Hold
32
– – ﹤0.01% 368
2025
Q3 		$12.5K Hold
32
– – ﹤0.01% 374
2025
Q2 		$14.2K Hold
32
– – 0.01% 342
2025
Q1 		$15.5K Hold
32
– – 0.01% 332
2024
Q4 		$12.9K Buy
+32
New +$14.8K 0.01% 349
2024
Q3 		– Sell
-32
Closed -$15K – 415
2024
Q2 		$15K Hold
32
– – 0.01% 336
2024
Q1 		$13.4K Hold
32
– – 0.01% 364
2023
Q4 		$13K Hold
32
– – 0.01% 371
2023
Q3 		$11.1K Buy
+32
New +$11.2K 0.01% 374
2023
Q2 		– Sell
-32
Closed -$10.1K – 422
2023
Q1 		$10.1K Buy
+32
New +$9.6K 0.01% 373

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Orion Capital Management's VRTX Position: Q1 2026 in Review

Orion Capital Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 32 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

Orion Capital Management first reported a position in VRTX in Q1 2023 and has held it in 11 quarters since. The position peaked at $15.5K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Orion Capital Management held 32 shares of Vertex Pharmaceuticals worth $14.3K as of Q1 2026.
  • Orion Capital Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Orion Capital Management's portfolio in Q1 2026, its #344 holding.
  • Orion Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
  • Orion Capital Management's Vertex Pharmaceuticals position peaked at $15.5K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Orion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.